-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- AbCellera Biologics Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$12.6M, a 770% decline year-over-year.
- AbCellera Biologics Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$37.5M, a 35.9% decline year-over-year.
- AbCellera Biologics Inc. annual Income Tax Expense (Benefit) for 2024 was -$37.5M, a 35.9% decline from 2023.
- AbCellera Biologics Inc. annual Income Tax Expense (Benefit) for 2023 was -$27.6M, a 134% decline from 2022.
- AbCellera Biologics Inc. annual Income Tax Expense (Benefit) for 2022 was $80.6M, a 22.7% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)